Search Within

Steven Maron

  1. "Biostatistics Service"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (15)
  3. Conference Paper (1)
  4. Miscellaneous (1)
Groups
  1. Biostatistics Service (39)
  2. Department of Medicine (39)
  3. Epidemiology and Biostatistics (39)
  4. Gastrointestinal Oncology Service (39)
  5. Solid Tumor Oncology Division (39)
  6. Survivorship Research (34)

More Groups

People
  1. Yelena Janjigian (34)
  2. Geoffrey Ku (30)
  3. David Ilson (23)
  4. Laura Tang (23)
  5. Marinela Capanu (22)
  6. Joanne Chou (20)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (12)
  4. 2022 (9)
  5. 2021 (6)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Annals of Surgery (5)
  3. Annals of Surgical Oncology (5)
  4. Annals of Oncology (3)
  5. Clinical Cancer Research (3)
  6. JAMA Network Open (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Springer (6)
  3. Lippincott Williams & Wilkins (5)
  4. American Association for Cancer Research (3)
  5. American Medical Association (3)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (39)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of neoadjuvant chemotherapy for clinical stages 2 and 3 gastric cancer patients: Analysis of timing and site of recurrence
    Journal Article

    Nakauchi, M.; Vos, E.; Tang, L. H.; Gonen, M.; Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Maron, S. B.; Yoon, S. S.; Brennan, M. F.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer
    Journal Article

    Ku, G. Y.; Kemel, Y.; Maron, S. B.; Chou, J. F.; Ravichandran, V.; Shameer, Z.; Maio, A.; Won, E. S.; Kelsen, D. P.; Ilson, D. H.; more...
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways
    Journal Article

    Sihag, S.; Nussenzweig, S. C.; Walch, H. S.; Hsu, M.; Tan, K. S.; Sanchez-Vega, F.; Chatila, W. K.; De La Torre, S. A.; Patel, A.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The interaction between microsatellite instability high (MSI-high) gastric cancer and chemotherapy on survival
    Meeting Abstract

    Vos, E. L.; Maron, S. B.; Krell, R. W.; Nakauchi, M.; Fiasconaro, M.; Walch, H. S.; Capanu, M.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save